Jeito Capital Co-Leads €78 Million Financing in Augustine Therapeutics
By Karen Roman Private equity company Jeito Capital said it is co-leading an oversubscribed €77.7 million (USD 84.8 million) ...
Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round
Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round Novo Holdings and Jeito Capital co-led the ...
Enid News & Eagle9d
Jeito Capital co-leads the oversubscribed €78 million financing in Augustine Therapeutics to ...
Jeito Capital co-leads the oversubscribed €78 million financing in Augustine Therapeutics to develop novel therapies for neuromuscular, cardio-metabolic and neurodegenerative diseases Proceeds ...
Finanznachrichten9d
Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round
The oversubscribed financing was co-led by Novo Holdings and Jeito Capital, supported by existing investors Asabys Partners, who led an initial EUR 17.5 million closing in 2024, Eli Lilly and ...
manilatimes8d
Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round
Novo Holdings and Jeito Capital co-led the deal, supported by Asabys Partners and existing investors Proceeds to support the clinical development of lead candidate AGT-100216 for the treatment of ...
Morningstar9d
Augustine Therapeutics raises oversubscribed EUR 78 million / USD 85 million Series A financing round
Novo Holdings and Jeito Capital co-led the deal, supported by Asabys Partners and existing investors Proceeds to support the clinical development of lead candidate AGT-100216 for the treatment of ...